Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 54

1.

Robot-assisted single-port radical prostatectomy: A phase 1 clinical study.

Ng CF, Teoh JY, Chiu PK, Yee CH, Chan CK, Hou SS, Kaouk J, Chan ES.

Int J Urol. 2019 Jun 30. doi: 10.1111/iju.14044. [Epub ahead of print]

PMID:
31257704
2.

Effect of stepwise voltage escalation on treatment outcomes following extracorporeal shockwave lithotripsy of renal calculi: a prospective randomized study.

Chi-Fai N, Yee CH, Teoh JY, Lau B, Leung SC, Wong CY, Tak WK, Chu WC, Yuen J.

J Urol. 2019 May 21:101097JU0000000000000344. doi: 10.1097/JU.0000000000000344. [Epub ahead of print]

PMID:
31112104
3.

Re: Agustina Bessa, Steven Maclennan, Deborah Enting, et al. Consensus in Bladder Cancer Research Priorities Between Patients and Healthcare Professionals Using a Four-stage Modified Delphi Method. Eur Urol 2019;76:260-1.

Inarritu JM, Castellani D, Teoh JYC; UroSoMe Working Group.

Eur Urol. 2019 Aug;76(2):e43-e44. doi: 10.1016/j.eururo.2019.05.005. Epub 2019 May 16. No abstract available.

PMID:
31103389
4.

Adolescent suicide attempts and ideation are linked to brain function during peer interactions.

Harms MB, Casement MD, Teoh JY, Ruiz S, Scott H, Wedan R, Quevedo K.

Psychiatry Res Neuroimaging. 2019 Jul 30;289:1-9. doi: 10.1016/j.pscychresns.2019.05.001. Epub 2019 May 4.

PMID:
31102892
5.

Noninvasive Detection of Bladder Cancer by Shallow-Depth Genome-Wide Bisulfite Sequencing of Urinary Cell-Free DNA for Methylation and Copy Number Profiling.

Cheng THT, Jiang P, Teoh JYC, Heung MMS, Tam JCW, Sun X, Lee WS, Ni M, Chan RCK, Ng CF, Chan KCA, Chiu RWK, Lo YMD.

Clin Chem. 2019 Jul;65(7):927-936. doi: 10.1373/clinchem.2018.301341. Epub 2019 Apr 15.

PMID:
30988170
6.

Amygdala Functional Connectivity During Self-Face Processing in Depressed Adolescents With Recent Suicide Attempt.

Alarcón G, Sauder M, Teoh JY, Forbes EE, Quevedo K.

J Am Acad Child Adolesc Psychiatry. 2019 Feb;58(2):221-231. doi: 10.1016/j.jaac.2018.06.036. Epub 2018 Nov 23. Erratum in: J Am Acad Child Adolesc Psychiatry. 2019 May;58(5):554.

PMID:
30738549
7.

Survey on prevalence of lower urinary tract symptoms in an Asian population.

Yee CH, Chan CK, Teoh JYC, Chiu PKF, Wong JHM, Chan ESY, Hou SSM, Ng CF.

Hong Kong Med J. 2019 Feb;25(1):13-20. doi: 10.12809/hkmj187502. Epub 2019 Jan 18.

8.

Transurethral resection of prostate for acute urinary retention is linked to shorter survival in younger men.

Teoh JY, Chan CK, Wang MH, Leung CH, Chan ES, Chiu PK, Yee CH, Wong HM, Hou SS, Ng CF.

Asian J Androl. 2019 Jan 15. doi: 10.4103/aja.aja_101_18. [Epub ahead of print]

9.

The Use of the da Vinci SP System for Retzius-sparing Radical Prostatectomy in Cadaveric Model.

Ng CF, Chan ESY, Teoh JYC.

Urology. 2019 Mar;125:260. doi: 10.1016/j.urology.2018.11.042. Epub 2018 Dec 21.

PMID:
30580003
10.

Updates in endourological management of urolithiasis.

Li JK, Teoh JY, Ng CF.

Int J Urol. 2019 Feb;26(2):172-183. doi: 10.1111/iju.13885. Epub 2018 Dec 21. Review.

PMID:
30575154
11.

A newly developed porcine training model for transurethral piecemeal and en bloc resection of bladder tumour.

Teoh JY, Cho CL, Wei Y, Isotani S, Tiong HY, Ong TA, Kijvikai K, Chu PS, Chan ES, Ng CF; Asian Urological Surgery Training & Education Group.

World J Urol. 2018 Dec 17. doi: 10.1007/s00345-018-2602-2. [Epub ahead of print]

PMID:
30560297
12.

Chemohormonal therapy for metastatic hormone-sensitive prostate cancer: An Asian perspective.

Teoh JY, Ng CF, Poon DM.

Asia Pac J Clin Oncol. 2018 Nov;14 Suppl 5:5-8. doi: 10.1111/ajco.13060. Review.

PMID:
30489034
13.

A Territory-wide, Multicenter, Age- and Prostate-specific Antigen-matched Study Comparing Chemohormonal Therapy and Hormonal Therapy Alone in Chinese Men With Metastatic Hormone-sensitive Prostate Cancer.

Teoh JYC, Poon DMC, Lam D, Chan T, Chan MFT, Lee EKC, Law S, Chan K, Cheng NM, Lai KM, Leung CH, Ng CF.

Clin Genitourin Cancer. 2019 Feb;17(1):e203-e208. doi: 10.1016/j.clgc.2018.10.010. Epub 2018 Oct 27.

PMID:
30454968
14.

Diagnosis of prostate cancer in a Chinese population by using machine learning methods.

Wang G, Teoh JY, Choi KS.

Conf Proc IEEE Eng Med Biol Soc. 2018 Jul;2018:1-4. doi: 10.1109/EMBC.2018.8513365.

PMID:
30440319
15.

A Multicentre Evaluation of the Role of the Prostate Health Index (PHI) in Regions with Differing Prevalence of Prostate Cancer: Adjustment of PHI Reference Ranges is Needed for European and Asian Settings.

Chiu PK, Ng CF, Semjonow A, Zhu Y, Vincendeau S, Houlgatte A, Lazzeri M, Guazzoni G, Stephan C, Haese A, Bruijne I, Teoh JY, Leung CH, Casale P, Chiang CH, Tan LG, Chiong E, Huang CY, Wu HC, Nieboer D, Ye DW, Bangma CH, Roobol MJ.

Eur Urol. 2019 Apr;75(4):558-561. doi: 10.1016/j.eururo.2018.10.047. Epub 2018 Nov 2.

PMID:
30396635
16.

Re: Valeria Panebianco, Yoshifumi Narumi, Ersan Altun, et al. Multiparametric Magnetic Resonance Imaging for Bladder Cancer: Development of VI-RADS (Vesical Imaging-Reporting And Data System). Eur Urol 74, 2018, 294-306.

Teoh JYC, Herrmann TRW, Babjuk M.

Eur Urol. 2019 Feb;75(2):e27-e28. doi: 10.1016/j.eururo.2018.09.007. Epub 2018 Sep 24. No abstract available.

PMID:
30262343
17.

Development of a novel and economical agar-based non-adherent three-dimensional culture method for enrichment of cancer stem-like cells.

Gao W, Wu D, Wang Y, Wang Z, Zou C, Dai Y, Ng CF, Teoh JY, Chan FL.

Stem Cell Res Ther. 2018 Sep 26;9(1):243. doi: 10.1186/s13287-018-0987-x.

18.

The cardiovascular risk factors in men with lower urinary tract symptoms.

Yee CH, Yip JSY, Cheng NMY, Kwan CH, Li KM, Teoh JYC, Chiu PKF, Wong JH, Chan ESY, Chan CK, Hou SSM, Ng CF.

World J Urol. 2019 Apr;37(4):727-733. doi: 10.1007/s00345-018-2432-2. Epub 2018 Aug 6.

PMID:
30083830
19.

Bipolar transurethral vapourisation versus monopolar transurethral resection of prostate: a randomised controlled trial.

Ng CF, Yee CH, Chan CK, Wong HM, Chiu PK, Tsu JH, Teoh JY, Ho KL.

Hong Kong Med J. 2017 Jun;23 Suppl 2(3):32-34. No abstract available.

20.

Orphan nuclear receptor TLX contributes to androgen insensitivity in castration-resistant prostate cancer via its repression of androgen receptor transcription.

Jia L, Wu D, Wang Y, You W, Wang Z, Xiao L, Cai G, Xu Z, Zou C, Wang F, Teoh JY, Ng CF, Yu S, Chan FL.

Oncogene. 2018 Jun;37(25):3340-3355. doi: 10.1038/s41388-018-0198-z. Epub 2018 Mar 20.

21.

Characteristics and clinical outcomes of living renal donors in Hong Kong.

Hong YL, Yee CH, Leung CB, Teoh JY, Kwan BC, Li PK, Hou SS, Ng CF.

Hong Kong Med J. 2018 Feb;24(1):11-17. doi: 10.12809/hkmj176820. Epub 2017 Dec 29.

22.

Extracorporeal Shockwave Lithotripsy Could Lead to a Prolonged Increase in the Renal Fibrotic Process of Up to 2 Years.

Ng CF, Luke S, Yee CH, Leung SCH, Teoh JYC, Yuen J.

J Endourol. 2018 Mar;32(3):223-229. doi: 10.1089/end.2017.0684. Epub 2018 Jan 9.

PMID:
29205049
23.

Nuclear receptor profiling in prostatospheroids and castration-resistant prostate cancer.

Wang Z, Wu D, Ng CF, Teoh JY, Yu S, Wang Y, Chan FL.

Endocr Relat Cancer. 2018 Jan;25(1):35-50. doi: 10.1530/ERC-17-0280. Epub 2017 Oct 17.

PMID:
29042395
24.

The Risk of Upper Urinary Tract Involvement in Patients With Ketamine-Associated Uropathy.

Yee CH, Teoh JY, Lai PT, Leung VY, Chu WC, Lee WM, Tam YH, Ng CF.

Int Neurourol J. 2017 Jun;21(2):128-132. doi: 10.5213/inj.1732704.352. Epub 2017 Jun 21.

25.

Genomewide bisulfite sequencing reveals the origin and time-dependent fragmentation of urinary cfDNA.

Cheng THT, Jiang P, Tam JCW, Sun X, Lee WS, Yu SCY, Teoh JYC, Chiu PKF, Ng CF, Chow KM, Szeto CC, Chan KCA, Chiu RWK, Lo YMD.

Clin Biochem. 2017 Jun;50(9):496-501. doi: 10.1016/j.clinbiochem.2017.02.017. Epub 2017 Feb 24.

26.

Secondary hemorrhage after bipolar transurethral resection and vaporization of prostate.

Yee CH, Wong JH, Chiu PK, Teoh JY, Chan CK, Chan ES, Hou SM, Ng CF.

Urol Ann. 2016 Oct-Dec;8(4):458-463. doi: 10.4103/0974-7796.192110.

27.

Differences in cancer characteristics of Chinese patients with prostate cancer who present with different symptoms.

Chan SY, Ng CF, Lee KW, Yee CH, Chiu PK, Teoh JY, Hou SS.

Hong Kong Med J. 2017 Feb;23(1):6-12. doi: 10.12809/hkmj164875. Epub 2016 Dec 9.

28.

Adaptation and external validation of the European randomised study of screening for prostate cancer risk calculator for the Chinese population.

Chiu PK, Roobol MJ, Nieboer D, Teoh JY, Yuen SK, Hou SM, Yiu MK, Ng CF.

Prostate Cancer Prostatic Dis. 2017 Mar;20(1):99-104. doi: 10.1038/pcan.2016.57. Epub 2016 Nov 29.

PMID:
27897172
29.

Prostatic artery embolization in treating benign prostatic hyperplasia: a systematic review.

Teoh JY, Chiu PK, Yee CH, Wong HM, Chan CK, Chan ES, Hou SS, Ng CF.

Int Urol Nephrol. 2017 Feb;49(2):197-203. doi: 10.1007/s11255-016-1461-2. Epub 2016 Nov 28. Review.

PMID:
27896579
30.

Comparison of Detrusor Muscle Sampling Rate in Monopolar and Bipolar Transurethral Resection of Bladder Tumor: A Randomized Trial.

Teoh JY, Chan ES, Yip SY, Tam HM, Chiu PK, Yee CH, Wong HM, Chan CK, Hou SS, Ng CF.

Ann Surg Oncol. 2017 May;24(5):1428-1434. doi: 10.1245/s10434-016-5700-7. Epub 2016 Nov 23.

PMID:
27882470
31.

Extended use of Prostate Health Index and percentage of [-2]pro-prostate-specific antigen in Chinese men with prostate specific antigen 10-20 ng/mL and normal digital rectal examination.

Chiu PK, Teoh JY, Lee WM, Yee CH, Chan ES, Hou SM, Ng CF.

Investig Clin Urol. 2016 Sep;57(5):336-42. doi: 10.4111/icu.2016.57.5.336. Epub 2016 Aug 31.

32.

Prostate health index (PHI) and prostate-specific antigen (PSA) predictive models for prostate cancer in the Chinese population and the role of digital rectal examination-estimated prostate volume.

Chiu PK, Roobol MJ, Teoh JY, Lee WM, Yip SY, Hou SM, Bangma CH, Ng CF.

Int Urol Nephrol. 2016 Oct;48(10):1631-7. doi: 10.1007/s11255-016-1350-8. Epub 2016 Jun 27.

PMID:
27349564
33.

Cardiovascular risk after androgen deprivation therapy for prostate cancer: an Asian perspective.

Teoh JY, Ng CF.

Int Urol Nephrol. 2016 Sep;48(9):1429-35. doi: 10.1007/s11255-016-1337-5. Epub 2016 Jun 2. Review.

PMID:
27256399
34.

"Aging males" symptoms and general health of adult males: a cross-sectional study.

Yuen JW, Ng CF, Chiu PK, Teoh JY, Yee CH.

Aging Male. 2016 Jun;19(2):71-8. doi: 10.3109/13685538.2016.1148130. Epub 2016 Apr 12.

PMID:
27068128
35.

Prostate Health Index and %p2PSA Predict Aggressive Prostate Cancer Pathology in Chinese Patients Undergoing Radical Prostatectomy.

Chiu PK, Lai FM, Teoh JY, Lee WM, Yee CH, Chan ES, Hou SM, Ng CF.

Ann Surg Oncol. 2016 Aug;23(8):2707-14. doi: 10.1245/s10434-016-5183-6. Epub 2016 Mar 10.

PMID:
26965697
36.

The performance characteristics of prostate-specific antigen and prostate-specific antigen density in Chinese men.

Teoh JY, Yuen SK, Tsu JH, Wong CK, Ho BS, Ng AT, Ma WK, Ho KL, Yiu MK.

Asian J Androl. 2017 Jan-Feb;19(1):113-116. doi: 10.4103/1008-682X.167103.

37.

Association of time to prostate-specific antigen nadir and logarithm of prostate-specific antigen velocity after progression in metastatic prostate cancer with prior primary androgen deprivation therapy.

Teoh JY, Tsu JH, Yuen SK, Chiu PK, Chan SY, Wong KW, Ho KL, Hou SS, Ng CF, Yiu MK.

Asian J Androl. 2017 Jan-Feb;19(1):98-102. doi: 10.4103/1008-682X.164921.

38.

Short-stay transurethral prostate surgery: A randomized controlled trial comparing transurethral resection in saline bipolar transurethral vaporization of the prostate with monopolar transurethral resection.

Yee CH, Wong JH, Chiu PK, Chan CK, Lee WM, Tsu JH, Teoh JY, Ng CF.

Asian J Endosc Surg. 2015 Aug;8(3):316-22. doi: 10.1111/ases.12197. Epub 2015 Jun 3.

PMID:
26042336
39.

Androgen deprivation therapy, diabetes and poor physical performance status increase fracture risk in Chinese men treated for prostate cancer.

Teoh JY, Chiu PK, Chan SY, Poon DM, Cheung HY, Hou SS, Ng CF.

Aging Male. 2015;18(3):180-5. doi: 10.3109/13685538.2015.1046043. Epub 2015 May 25.

PMID:
26004988
40.

The effect of renal cortical thickness on the treatment outcomes of kidney stones treated with shockwave lithotripsy.

Ng CF, Luke S, Chiu PK, Teoh JY, Wong KT, Hou SS.

Korean J Urol. 2015 May;56(5):379-85. doi: 10.4111/kju.2015.56.5.379. Epub 2015 Apr 28.

41.

Risk of ischemic stroke after androgen deprivation therapy for prostate cancer in the Chinese population living in Hong Kong.

Teoh JY, Chiu PK, Chan SY, Poon DM, Cheung HY, Hou SS, Ng CF.

Jpn J Clin Oncol. 2015 May;45(5):483-7. doi: 10.1093/jjco/hyv025. Epub 2015 Feb 26.

PMID:
25724216
42.

Prostate cancer detection upon transrectal ultrasound-guided biopsy in relation to digital rectal examination and prostate-specific antigen level: what to expect in the Chinese population?

Teoh JY, Yuen SK, Tsu JH, Wong CK, Ho BSh, Ng AT, Ma WK, Ho KL, Yiu MK.

Asian J Androl. 2015 Sep-Oct;17(5):821-5. doi: 10.4103/1008-682X.144945.

43.

Risk of cardiovascular thrombotic events after surgical castration versus gonadotropin-releasing hormone agonists in Chinese men with prostate cancer.

Teoh JY, Chan SY, Chiu PK, Poon DM, Cheung HY, Hou SS, Ng CF.

Asian J Androl. 2015 May-Jun;17(3):493-6. doi: 10.4103/1008-682X.143313.

44.

Survival outcomes of Chinese metastatic prostate cancer patients following primary androgen deprivation therapy in relation to prostate-specific antigen nadir level.

Teoh JY, Tsu JH, Yuen SK, Chan SY, Chiu PK, Wong KW, Ho KL, Hou SS, Ng CF, Yiu MK.

Asia Pac J Clin Oncol. 2017 Apr;13(2):e65-e71. doi: 10.1111/ajco.12313. Epub 2014 Dec 3.

PMID:
25471685
45.

Risk of acute myocardial infarction after androgen-deprivation therapy for prostate cancer in a Chinese population.

Teoh JY, Chan SY, Chiu PK, Poon DM, Cheung HY, Hou SS, Ng CF.

BJU Int. 2015 Sep;116(3):382-7. doi: 10.1111/bju.12967. Epub 2015 Mar 7.

46.

Risk of new-onset diabetes after androgen deprivation therapy for prostate cancer in the Asian population.

Teoh JY, Chiu PK, Chan SY, Poon DM, Cheung HY, Hou SS, Ng CF.

J Diabetes. 2015 Sep;7(5):672-80. doi: 10.1111/1753-0407.12226. Epub 2014 Dec 22.

PMID:
25266491
47.

Prognostic significance of time to prostate-specific antigen (PSA) nadir and its relationship to survival beyond time to PSA nadir for prostate cancer patients with bone metastases after primary androgen deprivation therapy.

Teoh JY, Tsu JH, Yuen SK, Chan SY, Chiu PK, Lee WM, Wong KW, Ho KL, Hou SS, Ng CF, Yiu MK.

Ann Surg Oncol. 2015 Apr;22(4):1385-91. doi: 10.1245/s10434-014-4105-8. Epub 2014 Sep 19.

PMID:
25234025
48.

Role of PSA density in diagnosis of prostate cancer in obese men.

Chiu PK, Teoh JY, Chan SY, Chu PS, Man CW, Hou SM, Ng CF.

Int Urol Nephrol. 2014 Dec;46(12):2251-4. doi: 10.1007/s11255-014-0826-7. Epub 2014 Sep 9.

PMID:
25201460
49.

Inflammatory myofibroblastic tumors of the urinary bladder: a systematic review.

Teoh JY, Chan NH, Cheung HY, Hou SS, Ng CF.

Urology. 2014 Sep;84(3):503-8. doi: 10.1016/j.urology.2014.05.039. Review.

PMID:
25168523
50.

Inflammatory myofibroblastic tumours of the urinary bladder: multi-centre 18-year experience.

Teoh JY, Chan NH, Mak SM, Lo AW, Leung CY, Hui Y, Law IC, Fan CW, Cheung FK, Chan SW, Yiu MK, Man CW, So HS, Cheung HY, Hou SS, Ng CF.

Urol Int. 2015;94(1):31-6. doi: 10.1159/000358732. Epub 2014 Jul 18.

PMID:
25059529

Supplemental Content

Support Center